annual ROE:
-17.90%+16.89%(+48.55%)Summary
- As of today (September 9, 2025), VKTX annual return on equity is -17.90%, with the most recent change of +16.89% (+48.55%) on December 31, 2024.
- During the last 3 years, VKTX annual ROE has risen by +6.75% (+27.38%).
- VKTX annual ROE is now -117.00% below its all-time high of 105.31%, reached on December 31, 2012.
Performance
VKTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-19.70%-5.43%(-38.05%)Summary
- As of today (September 9, 2025), VKTX quarterly return on equity is -19.70%, with the most recent change of -5.43% (-38.05%) on June 30, 2025.
- Over the past year, VKTX quarterly ROE has dropped by -3.34% (-20.42%).
- VKTX quarterly ROE is now -107.58% below its all-time high of 259.95%, reached on June 30, 2015.
Performance
VKTX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VKTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.5% | -20.4% |
| 3 y3 years | +27.4% | +34.2% |
| 5 y5 years | -99.5% | -67.5% |
VKTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.9% | -43.2% | +57.6% |
| 5 y | 5-year | -99.5% | +54.9% | -67.5% | +57.6% |
| alltime | all time | -117.0% | +93.3% | -107.6% | +99.5% |
VKTX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -19.70%(+38.1%) |
| Mar 2025 | - | -14.27%(+3.7%) |
| Dec 2024 | -17.90%(-48.5%) | -13.76%(-3.3%) |
| Sep 2024 | - | -14.23%(-13.0%) |
| Jun 2024 | - | -16.36%(-24.2%) |
| Mar 2024 | - | -21.59%(-30.5%) |
| Dec 2023 | -34.79%(-12.3%) | -31.07%(-8.9%) |
| Sep 2023 | - | -34.11%(-9.6%) |
| Jun 2023 | - | -37.72%(-18.8%) |
| Mar 2023 | - | -46.45%(+14.1%) |
| Dec 2022 | -39.67%(+60.9%) | -40.70%(+20.6%) |
| Sep 2022 | - | -33.74%(+12.7%) |
| Jun 2022 | - | -29.94%(+11.1%) |
| Mar 2022 | - | -26.94%(+9.9%) |
| Dec 2021 | -24.65%(+62.7%) | -24.52%(+7.4%) |
| Sep 2021 | - | -22.83%(+12.5%) |
| Jun 2021 | - | -20.30%(+17.3%) |
| Mar 2021 | - | -17.31%(+14.4%) |
| Dec 2020 | -15.15%(+68.9%) | -15.13%(+13.0%) |
| Sep 2020 | - | -13.39%(+13.9%) |
| Jun 2020 | - | -11.76%(+8.7%) |
| Mar 2020 | - | -10.82%(+21.0%) |
| Dec 2019 | -8.97% | -8.94%(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -8.04%(-13.0%) |
| Jun 2019 | - | -9.24%(-12.7%) |
| Mar 2019 | - | -10.58%(-20.7%) |
| Dec 2018 | -14.18%(-92.6%) | -13.35%(-32.2%) |
| Sep 2018 | - | -19.70%(-54.6%) |
| Jun 2018 | - | -43.37%(-53.0%) |
| Mar 2018 | - | -92.27%(-66.0%) |
| Dec 2017 | -191.35%(+8.9%) | -271.71%(-6.6%) |
| Sep 2017 | - | -290.82%(+47.3%) |
| Jun 2017 | - | -197.49%(+7.1%) |
| Mar 2017 | - | -184.46%(+14.0%) |
| Dec 2016 | -175.71%(-34.5%) | -161.74%(+1.5%) |
| Sep 2016 | - | -159.33%(+7.9%) |
| Jun 2016 | - | -147.62%(-76.0%) |
| Mar 2016 | - | -614.31%(-24.2%) |
| Dec 2015 | -268.24%(-371.2%) | -810.52%(-81.4%) |
| Sep 2015 | - | -4364.00%(-1778.8%) |
| Jun 2015 | - | 259.95%(+133.1%) |
| Mar 2015 | - | 111.53%(-42.5%) |
| Dec 2014 | 98.90%(+66.5%) | - |
| Jun 2014 | - | 193.89%(+345.7%) |
| Mar 2014 | - | 43.50% |
| Dec 2013 | 59.41%(-43.6%) | - |
| Dec 2012 | 105.31% | - |
FAQ
- What is Viking Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual ROE year-on-year change?
- What is Viking Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly ROE year-on-year change?
What is Viking Therapeutics, Inc. annual return on equity?
The current annual ROE of VKTX is -17.90%
What is the all time high annual ROE for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual return on equity is 105.31%
What is Viking Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, VKTX annual return on equity has changed by +16.89% (+48.55%)
What is Viking Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of VKTX is -19.70%
What is the all time high quarterly ROE for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly return on equity is 259.95%
What is Viking Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, VKTX quarterly return on equity has changed by -3.34% (-20.42%)